Home|Journals|Articles by Year

Directory for Medical Articles

Open Access

Original Research

RMJ. 2019; 44(1): 86-88

Prevalence of patellofemoral pain disorder or anterior knee pain in both genders ages between 18-35.

Zoya Mujahid, Waqar Afzal, Ashfaq Ahmad, Syed Amir Gilani, Fatima Akram, Asifa Ashiq.

Objective: To evaluate prevalence of patellofemoral pain disorder or anterior knee pain (AKP) in both genders ages between18-35.
Methodology: The subjects were taken from different hospitals of Lahore, Pakistan. All were requested to fill the Anterior Knee Pain Questionnaire (AKPQ).
Results: Out of 400 subjects, 205(51.3%) were male and 195(48.8%) female. The mean age was 24.645.346, mean height 5.44460.37948ft and mean weight was 59.468.931kg. The mean score on AKPQ was 92.8212.382. Out of 400, 76 (19.0%) scored less than 83, this considered positive for Patellofemoral Pain Syndrome or AKP. 34(16.58%) out of 205 males scored less than 83 and 42(21.53%), females out of 195 scored less than 83. 116(56.58%) out of 205 males scored 100 and considered normal, 102(52.30%) out of 195 females have scored 100. 54(26.34%) out of 205 scored greater than 83, 52(26.66%) out of 195 females scored greater than 83.
Conclusion: Anterior knee pain or Patellofemoral pain syndrome was present among young individuals of age between 18 and 35 years. AKP affects the activities of daily living. Most subjects with positive score had difficulty in knee flexion and had pain that disturbed their overall performance. Patellofemoral pain disorder is more prevalent in females than males.

Key words: Anterior knee pain, patellofemoral pain disorder, physical activities.

Similar Articles

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Journal Finder
Covid-19 Trends and Statistics
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.